priors.science/reviews/alzheimers-disease-treatment

Alzheimers Disease Treatment

The current evidence on 12 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty — how firmly the literature supports the claim as stated.

12claims tracked
212primary papers reviewed
9 Aug 2026latest evidence review
Weeklyre-scored against new papers
2 Established · 4 Likely · 5 Uncertain · 1 Doubtful  |  four-reviewer panel · PICO Framework
ClaimStandingEvidence certaintyCorpus
Donanemab slows decline in early Alzheimer's diseaseAmyloid ImmunotherapyEstablished85%21
Cholinesterase inhibitors give symptomatic benefitSymptomaticLikely84%20
Lecanemab slows decline in early Alzheimer's diseaseAmyloid ImmunotherapyEarly evidenceLikely83%22
Plasma phosphorylated tau 217 detects Alzheimer's pathologyBiomarkersLikely83%24
Memantine helps moderate-to-severe Alzheimer's diseaseSymptomaticLikely74%20
Multidomain lifestyle slows declinePreventionUncertain66%19
Exercise reduces cognitive declinePreventionUncertain66%25
Midlife cardiovascular risk control cuts dementiaPreventionUncertain65%23
Amyloid positron emission tomography reduction predicts benefitBiomarkersUncertain55%20
Memantine plus cholinesterase inhibitor beats monotherapySymptomaticUncertain55%20
Aducanumab clinically beneficialAmyloid ImmunotherapyEarly evidenceDoubtful36%20
Track Alzheimers Disease Treatment.
These claims are re-scored against new papers every week. Track this topic for the full review, including each claim’s challenge and the papers behind it.
Track this topic →
Standing — what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely70–84%Well supported, with some gaps or indirect evidence.
Uncertain50–69%Mixed or limited evidence. Genuinely open.
Doubtful30–49%Little support; the weight of evidence leans against it.
Refuted< 30%The evidence contradicts it — confidently false as stated.
Where the evidence sits in time
Early evidenceMost of this evidence is from the last two years.